2013
DOI: 10.1016/j.atherosclerosis.2013.02.035
|View full text |Cite
|
Sign up to set email alerts
|

Serum monomeric α2-macroglobulin as a clinical biomarker in diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 28 publications
2
18
0
1
Order By: Relevance
“…showed that the bone-marrow-derived CD133(+) endothelial progenitor cells and CD14(+) monocytes may contribute to vasculogenesis in PDR. [47] Serum monomeric α2-macroglobulin was highly expressed in many diabetic patients as compared to respective control in a study done by Takada et al .,[48] Shiba et al . demonstrated that vitreous fluid sLR11 level may be a novel risk factor for the early development of PDR before the increase in circulating levels in diabetic patients.…”
Section: Circulating Biomarkers In Diabetic Retinopathymentioning
confidence: 99%
“…showed that the bone-marrow-derived CD133(+) endothelial progenitor cells and CD14(+) monocytes may contribute to vasculogenesis in PDR. [47] Serum monomeric α2-macroglobulin was highly expressed in many diabetic patients as compared to respective control in a study done by Takada et al .,[48] Shiba et al . demonstrated that vitreous fluid sLR11 level may be a novel risk factor for the early development of PDR before the increase in circulating levels in diabetic patients.…”
Section: Circulating Biomarkers In Diabetic Retinopathymentioning
confidence: 99%
“…Since Smith and colleagues have already reported that haptoglobin levels were not significantly different between 10 BR and 20 WR kept in captivity [8], it may not play an important role in the BR’s α 2 -globulin increase in the present study. α 2 -macroglobulin inhibits numerous endogenous proteases and acts as a transport protein for cytokines and growth factors [57]. Increased α 2 -macroglobulin is favored by inflammatory states, such as diabetes mellitus in humans [57].…”
Section: Discussionmentioning
confidence: 99%
“…α 2 -macroglobulin inhibits numerous endogenous proteases and acts as a transport protein for cytokines and growth factors [57]. Increased α 2 -macroglobulin is favored by inflammatory states, such as diabetes mellitus in humans [57]. Ceruloplasmin levels increase with inflammation in humans [58].…”
Section: Discussionmentioning
confidence: 99%
“…Важную роль в профилактике КРС 2-го типа играет оптимальное управление балансом натрия и экстрацеллюляр-ной жидкости, что достигается при низкосолевой диете и адекватном использовании диуретических препаратов [63]. Лекарственными средствами, снижающими заболеваемость и смертность, по-тенциально замедляющими прогрессирование ХСН, являются иАПФ, бета-адреноблокаторы, АРА и антагонисты альдостерона.…”
Section: ëå÷åáíàÿ òàêòèêà ïðè êðñ 2-ãî òèïàunclassified